ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that it has entered into an agreement with BrainCool, a medical device company specializing in temperature management solutions, for the exclusive distribution of the BrainCool™ System/IQool System and the IQool System Pads in the U.S. and key markets in Europe, and are working towards expanding distribution to select markets in Asia.
The agreement expands ZOLL’s portfolio of temperature management solutions to include both intravascular technology and surface options — providing clinicians with choices for advanced solutions with precise temperature control and intelligent analytics.
The BrainCool™ System (branded the IQool™ System in the United States) is an advanced surface temperature management system with gel-free and adhesive-free pads that maintains fever control and manages patient temperature in critical care settings. The IQool System features an intuitive user interface, programmable protocol settings and acute temperature control.
“Expanding ZOLL’s temperature management offering to include a high-quality surface option supports our mission to improve patient outcomes and help save lives,” stated Christopher Barnabas, President of ZOLL Circulation. “With our Thermogard XP® and Thermogard HQ™ products — the world’s only intravascular temperature management technology — and BrainCool’s IQool System, we now offer a unique combination of solutions that deliver high-quality patient care while recognizing hospitals’ evolving protocols and increased nursing workload.”
SOURCE: Businesswire